Additional studies further demonstrate that PRMT1 drives tumor proliferation through distinct mechanisms, including regulation of translation in osteosarcoma, activation of mTORC1 signaling in hepatocellular carcinoma, and transcriptional control of cell-cycle progression in glioma and multiple myeloma [180, 286–288]. Here, PRMT1 is linked to neoplasm.